Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christina, L Roland"'
Autor:
Abhineet, Uppal, Anai N, Kothari, Christopher P, Scally, Christina L, Roland, Brian K, Bednarski, Matthew H G, Katz, Jean-Nicholas, Vauthey, George J, Chang
Publikováno v:
JCO Oncology Practice. 18:e1091-e1099
PURPOSE: The COVID-19 pandemic has resulted in significant changes in health care delivery, including the rapid adoption of telemedicine across multiple specialties and practice environments. This includes postoperative visits (POV), despite limited
Autor:
Dian Wang, Katherine E Santoro, Christina L. Roland, Sonia Cohen, Gregory M. Cote, Beow Y. Yeap, Gunnlaugur P. Nielsen, Andrew J. Bishop, Edwin Choy, Christopher Lescinskas, Ivy A. Petersen, Alex B. Haynes, Sam S. Yoon, Yen-Lin Chen, John T. Mullen, Thomas F. DeLaney
Publikováno v:
Journal of Clinical Oncology. 39:11550-11550
11550 Background: RPS often have local recurrence (LR) after surgery. Preoperative radiation (RT) to 50.4 Gy can reduce LR risk but is not uniformly effective, especially after (+) margin resections. Therefore, we conducted a multi-institutional, pro
Autor:
Hussein Abdul-Hassan Tawbi, Christina L. Roland, Shreyaskumar Patel, Alexander J. Lazar, Emily Z. Keung, Ashleigh Guadagnolo, Kelly K. Hunt, Justin E. Bird, Ravin Ratan, Barry W. Feig, Keila E. Torres, Andrew J. Bishop, Jennifer A. Wargo, Neeta Somaiah, Wei-Lien Wang, Heather Lin, Valerae O. Lewis
Publikováno v:
Journal of Clinical Oncology. 38:11505-11505
11505 Background: is a randomized, phase II non-comparative trial evaluating the efficacy of neoadjuvant checkpoint blockade [nivolumab (N) or ipilimumab/ nivolumab (I/N)] in patients (pts) with surgically resectable retroperitoneal DDLPS or extremit
Autor:
Sharjeel H. Sabir, Neeta Somaiah, Anthony P. Conley, Behrang Amini, Ignacio I. Wistuba, Dejka M. Araujo, Christina L. Roland, Shreyaskumar Patel, Najat C. Daw, Heather Lin, Alexander J. Lazar, Maria Alejandra Zarzour, Taylor Tate, Andrew Futreal, Robert S. Benjamin, Patrick Hwu, Ravin Ratan, Wei-Lien Wang, Vinod Ravi, J. Andrew Livingston
Publikováno v:
Journal of Clinical Oncology. 38:11509-11509
11509 Background: The combination of durvalumab (D), (anti- PD-L1) and tremelimumab (T), (anti-CTLA-4), was evaluated to determine activity in specific sarcoma subtypes (NCT02815995). We report final results of the clinical efficacy, safety and corre
Autor:
Carolyn S. Hall, Christina L. Roland, Merrick I. Ross, Richard E. Royal, Mandar Karhade, Anthony Lucci, Barbara Laubacher, Joshua Upshaw, Jessica B. Bowman Bauldry
Publikováno v:
Journal of Clinical Oncology. 33:9016-9016
9016 Background: There is a need for more sensitive and specific prognostic markers for advanced stage melanoma patients to help improve the risk-benefit ratio of systemic adjuvant therapies. While...
Autor:
Andrew Futreal, Funda Meric-Bernstam, Vivek Subbiah, Wei-Lien Wang, Neeta Somaiah, Robert S. Benjamin, Patrick Hwu, Barry W. Feig, Shreyaskumar Patel, Alexander J. Lazar, Kenna Rael Shaw, Vinod Ravi, Davis R. Ingram, Hannah C. Beird, Christina L. Roland, David S. Hong, Anthony P. Conley, Keila E. Torres
Publikováno v:
Journal of Clinical Oncology. 33:10550-10550
10550 Background: WD/DD LPS is a common soft tissue sarcoma with approximately 1500 new cases per year. Surgery is the mainstay of treatment but recurrences are frequent and limited systemic option...
Autor:
Ya'an Kang, Jason B. Fleming, Deyali Chatterjee, Jeffrey E. Lee, Jeannelyn S. Estrella, Asif Rashid, Christina L. Roland, James C. Yao
Publikováno v:
Journal of Clinical Oncology. 32:250-250
250 Background: Studies by comparative genomic hybridization have demonstrated that the 18q chromosomal region is frequently lost in gastrointestinal neuroendocrine tumors (GI-NET). However, the impact of DPC/SMAD4 loss, which is located 18q21, in th